T. Wolff

1.8k total citations · 1 hit paper
33 papers, 1.6k citations indexed

About

T. Wolff is a scholar working on Pharmacology, Molecular Biology and Cancer Research. According to data from OpenAlex, T. Wolff has authored 33 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmacology, 11 papers in Molecular Biology and 11 papers in Cancer Research. Recurrent topics in T. Wolff's work include Pharmacogenetics and Drug Metabolism (12 papers), Carcinogens and Genotoxicity Assessment (10 papers) and Drug Transport and Resistance Mechanisms (7 papers). T. Wolff is often cited by papers focused on Pharmacogenetics and Drug Metabolism (12 papers), Carcinogens and Genotoxicity Assessment (10 papers) and Drug Transport and Resistance Mechanisms (7 papers). T. Wolff collaborates with scholars based in Germany, Czechia and Slovakia. T. Wolff's co-authors include F. Peter Guengerich, M V Martin, P. Kremers, David J. Waxman, Philippe Beaune, L.R. Schwarz, E. Deml, Jan Topinka, Friedrich J. Wiebel and Sabine Werner and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

T. Wolff

33 papers receiving 1.5k citations

Hit Papers

Characterization of rat and human liver microsomal cytoch... 1986 2026 1999 2012 1986 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Wolff Germany 18 944 485 412 353 240 33 1.6k
Sang S. Park United States 24 1.3k 1.3× 458 0.9× 608 1.5× 381 1.1× 472 2.0× 49 2.1k
F. Peter Guengerich United States 18 1.7k 1.8× 705 1.5× 624 1.5× 320 0.9× 157 0.7× 28 2.2k
F.Peter Guengerich United States 11 912 1.0× 367 0.8× 694 1.7× 481 1.4× 266 1.1× 12 1.8k
T. Kamataki Japan 9 989 1.0× 424 0.9× 675 1.6× 161 0.5× 111 0.5× 13 1.7k
Masayuki Komori Japan 24 952 1.0× 424 0.9× 732 1.8× 204 0.6× 102 0.4× 70 1.7k
Ivan Gut Czechia 26 690 0.7× 695 1.4× 763 1.9× 431 1.2× 125 0.5× 63 2.0k
F. Peter Guengerich United States 12 864 0.9× 360 0.7× 670 1.6× 353 1.0× 115 0.5× 14 1.7k
Linda C. Quattrochi United States 26 1.5k 1.6× 736 1.5× 872 2.1× 488 1.4× 432 1.8× 48 2.7k
Noritaka Ariyoshi Japan 26 999 1.1× 452 0.9× 715 1.7× 142 0.4× 199 0.8× 85 2.0k
Mitsukazu Kitada Japan 23 1.3k 1.3× 555 1.1× 588 1.4× 212 0.6× 79 0.3× 80 1.9k

Countries citing papers authored by T. Wolff

Since Specialization
Citations

This map shows the geographic impact of T. Wolff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Wolff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Wolff more than expected).

Fields of papers citing papers by T. Wolff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Wolff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Wolff. The network helps show where T. Wolff may publish in the future.

Co-authorship network of co-authors of T. Wolff

This figure shows the co-authorship network connecting the top 25 collaborators of T. Wolff. A scholar is included among the top collaborators of T. Wolff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Wolff. T. Wolff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Topinka, Jan, Paola Loli, Zuzana Kovačíková, et al.. (2005). Benzo[a]pyrene-enhanced mutagenesis by man-made mineral fibres in the lung of λ-lacI transgenic rats. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 595(1-2). 167–173. 3 indexed citations
2.
Topinka, Jan, Paola Loli, Mária Dušinská, et al.. (2005). Mutagenesis by man-made mineral fibres in the lung of rats. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 595(1-2). 174–183. 16 indexed citations
3.
Topinka, Jan, Paola Loli, Panagiotis Georgiadis, et al.. (2004). Mutagenesis by asbestos in the lung of λ-lacI transgenic rats. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 553(1-2). 67–78. 30 indexed citations
4.
Loli, Paola, Jan Topinka, Panagiotis Georgiadis, et al.. (2004). Benzo[a]pyrene-enhanced mutagenesis by asbestos in the lung of λ-lacI transgenic rats. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 553(1-2). 79–90. 12 indexed citations
5.
Wolff, T., Jan Topinka, E. Deml, Doris Oesterle, & L.R. Schwarz. (2001). Dose Dependent Induction of DNA Adducts, Gene Mutations, and Cell Proliferation by the Antiandrogenic Drug Cyproterone Acetate in Rat Liver. Advances in experimental medicine and biology. 500. 687–696. 8 indexed citations
6.
Topinka, Jan, L.R. Schwarz, Friedrich J. Wiebel, Milena Černá, & T. Wolff. (2000). Genotoxicity of urban air pollutants in the Czech Republic. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 469(1). 83–93. 68 indexed citations
7.
Topinka, Jan, L.R. Schwarz, Franz Kiefer, et al.. (1998). DNA adduct formation in mammalian cell cultures by polycyclic aromatic hydrocarbons (PAH) and nitro-PAH in coke oven emission extract. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 419(1-3). 91–105. 50 indexed citations
8.
Werner, Sabine, et al.. (1997). Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 395(2-3). 179–187. 23 indexed citations
9.
Topinka, Jan, Blanka Binková, L.R. Schwarz, & T. Wolff. (1996). SHORT COMMUNICATION: Cyproterone acetate is an integral part of hepatic DNA adducts induced by this steroidal drug. Carcinogenesis. 17(1). 167–170. 10 indexed citations
10.
Werner, Sabine, et al.. (1996). Studies on the Formation of Hepatic DNA Adducts by the Antiandrogenic and Gestagenic Drug, Cyproterone Acetate. Advances in experimental medicine and biology. 387. 253–257. 1 indexed citations
11.
Schwarz, L.R., et al.. (1996). The Liver as Origin and Target of Reactive Intermediates Exemplified by the Progesterone Derivative, Cyproterone Acetate. Advances in experimental medicine and biology. 387. 243–251. 5 indexed citations
12.
Werner, Sabine, et al.. (1995). Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver. Carcinogenesis. 16(10). 2369–2372. 18 indexed citations
13.
Topinka, Jan, Blanka Binková, U. Andrae, et al.. (1995). DNA-damaging activity of the cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver. Carcinogenesis. 16(7). 1483–1487. 25 indexed citations
14.
Withold, Wolfgang, et al.. (1995). Evaluation of a radioimmunoassay for determination of calcitriol in human sera employing a 125I-labelled tracer.. PubMed. 33(12). 959–63. 2 indexed citations
15.
Binková, Blanka, Lubomı́r Dobiáš, T. Wolff, & Radim J. Šrám. (1994). 32P-postlabeling analysis of DNA adducts in tissues of rats exposed to coke-oven emissions. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 307(1). 355–363. 14 indexed citations
16.
Topinka, Jan, U. Andrae, L.R. Schwarz, & T. Wolff. (1993). Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures. Carcinogenesis. 14(3). 423–427. 56 indexed citations
17.
Wolff, T., et al.. (1992). Endogenous and exogenous factors modifying the activity of human liver cytochrome P-450 enzymes. Experimental and Toxicologic Pathology. 44(5). 263–271. 9 indexed citations
18.
Deml, E., Doris Oesterle, T. Wolff, & Helmut Greim. (1981). Age-, sex-, and strain-dependent differences in the induction of enzyme-altered islands in rat liver by diethylnitrosamine. Journal of Cancer Research and Clinical Oncology. 100(2). 125–134. 22 indexed citations
19.
Wiebel, Friedrich J., et al.. (1980). Presence of cytochrome P-450- and cytochrome P-448-dependent monooxygenase functions in hepatoma cell lines. Biochemical and Biophysical Research Communications. 94(2). 466–472. 50 indexed citations
20.
Wolff, T., et al.. (1979). Aldrin epoxidation, a highly sensitive indicator specific for cytochrome P-450-dependent mono-oxygenase activities.. Drug Metabolism and Disposition. 7(5). 301–305. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026